Clinical Trials Browser

Phase 2 × Completed × Metastatic Castration-resistant Prostate Cancer (mCRPC) × Clear all

NCT04862091 2022-03-04

Comparative Study of Abiraterone Acetate Tablets (I) or ZYTIGA® in Patients With Metastatic Castration-resistant Prostate Cancer

Phase 2 Completed

Metastatic Castration-resistant Prostate Cancer (mCRPC)